HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael B Armstrong Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

11/2013Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael B Armstrong Research Topics

Disease

5Neuroblastoma
12/2013 - 11/2006
1Neoplasms (Cancer)
11/2013
1Hepatoblastoma
08/2012
1Heart Arrest (Cardiac Arrest)
08/2012
1Iron Deficiencies
01/2012
1Anemia
01/2012
1Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
11/2005

Drug/Important Bio-Agent (IBA)

2NF-kappa B (NF-kB)IBA
11/2006 - 11/2006
1Protein Isoforms (Isoforms)IBA
12/2013
1betaglycan (TGFBR3)IBA
11/2013
1Messenger RNA (mRNA)IBA
11/2013
1Biomarkers (Surrogate Marker)IBA
11/2013
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2013
1Vincristine (Oncovin)FDA LinkGeneric
08/2012
1IronIBA
01/2012
1Cisplatin (Platino)FDA LinkGeneric
01/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2008
1Irinotecan (Camptosar)FDA LinkGeneric
01/2008
1Etoposide (VP 16)FDA LinkGeneric
01/2008
1Bortezomib (Velcade)FDA Link
01/2008
1Carboplatin (JM8)FDA LinkGeneric
01/2008
1SteroidsIBA
11/2005
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2005

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2006 - 11/2006
1Therapeutics
08/2012
1Immunomodulation
11/2005
1Plasmapheresis
11/2005